Cas:400090-60-0 (R)-3-AMINO PENTANENITRILE manufacturer & supplier

We serve Chemical Name:(R)-3-AMINO PENTANENITRILE CAS:400090-60-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(R)-3-AMINO PENTANENITRILE

Chemical Name:(R)-3-AMINO PENTANENITRILE
CAS.NO:400090-60-0
Synonyms:Pentanenitrile,3-amino-,(3R);R-3-aminopentanenitrile;(3R)-3-azanylpentanenitrile;(R)-3-aminopentanitrile;r-apn;(R)-3-AMINO PENTANENITRILE
Molecular Formula:C5H10N2
Molecular Weight:98.14630
HS Code:2926909090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:202.74ºC at 760 mmHg
Density:0.905g/cm3
Index of Refraction:1.44
PSA:49.81000
Exact Mass:98.08440
LogP:1.33768

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Pentanenitrile,3-amino-,(3R) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(R)-3-AMINO PENTANENITRILE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pentanenitrile,3-amino-,(3R) Use and application,Pentanenitrile,3-amino-,(3R) technical grade,usp/ep/jp grade.


Related News: From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. (R)-3-AMINO PENTANENITRILE manufacturer In addition, due to the complex process of changing the API supplier and the risk of uncertainty, the viscosity of pharmaceutical and specialty API companies is usually better. (R)-3-AMINO PENTANENITRILE supplier In addition, due to environmental constraints, Yancheng Lianhua’s first pesticide project ANBE was put into operation at a slower pace than expected, and other pesticide projects were also put into operation. (R)-3-AMINO PENTANENITRILE vendor From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said. (R)-3-AMINO PENTANENITRILE factory From the three-month point onward, 84.5% of uMRD patients maintained that deep remission in the blood to the 12-month assessment. These data show the new combo can deliver “very durable remissions” for the vast majority of patients, Tendler said.